Using inverse-weighting in cost-effectiveness analysis with censored data
暂无分享,去创建一个
R J Cook | A R Willan | A. Willan | R. Cook | R. Cook | D Y Lin | E B Chen | D. Lin | E. B. Chen | Danyu Lin
[1] S. Stearns,et al. Estimating confidence intervals for cost-effectiveness ratios: an example from a randomized trial. , 1996, Statistics in medicine.
[2] A H Briggs,et al. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. , 1997, Health economics.
[3] A R Willan,et al. Analysis, sample size, and power for estimating incremental net health benefit from clinical trial data. , 2001, Controlled clinical trials.
[4] Johan L. Severens,et al. ECONOMIC EVALUATION OF DIAGNOSTIC TESTS , 1999, International Journal of Technology Assessment in Health Care.
[5] A H Briggs,et al. Power and Sample Size Calculations for Stochastic Cost-Effectiveness Analysis , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.
[6] Frank A. Sloan,et al. Valuing health care , 1996 .
[7] D Y Lin,et al. Incremental net benefit in randomized clinical trials , 2001, Statistics in medicine.
[8] E. Pulkstenis,et al. Estimation of mean quality adjusted survival time. , 1999, Statistics in medicine.
[9] E. Feuer,et al. Estimating medical costs from incomplete follow-up data. , 1997, Biometrics.
[10] A H Briggs,et al. A Bayesian approach to stochastic cost-effectiveness analysis. , 1999, Health economics.
[11] Testing Equality of Survival Functions of Quality‐Adjusted Lifetime , 2001, Biometrics.
[12] Andrew R Willan,et al. Is there a kink in consumers' threshold value for cost-effectiveness in health care? , 2002, Health economics.
[13] J. Mullahy,et al. Valuing health care: Statistical issues in cost–effectiveness analyses , 1995 .
[14] A H Briggs,et al. Constructing confidence intervals for cost-effectiveness ratios: an evaluation of parametric and non-parametric techniques using Monte Carlo simulation. , 1999, Statistics in medicine.
[15] A J Moskowitz,et al. Bayesian estimation of cost-effectiveness ratios from clinical trials. , 1999, Health economics.
[16] D. Lin,et al. Linear regression analysis of censored medical costs. , 2000, Biostatistics.
[17] Morris Meisner,et al. Power and Sample Size in Cost- Effectiveness Analysis , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.
[18] D. Heitjan,et al. Fieller's method and net health benefits. , 2000, Health economics.
[19] E. M. Konst,et al. UNCERTAINTY OF INCREMENTAL COST-EFFECTIVENESS RATIOS , 1999, International Journal of Technology Assessment in Health Care.
[20] C E Phelps,et al. On the (Near) Equivalence of Cost-Effectiveness and Cost-Benefit Analyses , 1991, International Journal of Technology Assessment in Health Care.
[21] Anthony O'Hagan,et al. On estimators of medical costs with censored data. , 2004, Journal of health economics.
[22] A R Willan,et al. Cost-effectiveness analysis when the WTA is greater than the WTP. , 2001, Statistics in medicine.
[23] P. Wakker,et al. Confidence intervals for cost/effectiveness ratios. , 1995, Health economics.
[24] Anastasios A. Tsiatis,et al. A consistent estimator for the distribution of quality adjusted survival time , 1997 .
[25] J. Hwang,et al. Estimation of expected quality adjusted survival by cross-sectional survey. , 1996, Statistics in medicine.
[26] D Polsky,et al. Confidence intervals for cost-effectiveness ratios: a comparison of four methods. , 1997, Health economics.
[27] A H Briggs,et al. Handling uncertainty in economic evaluations of healthcare interventions , 1999, BMJ.
[28] Anastasios A. Tsiatis,et al. Estimating medical costs with censored data , 2000 .
[29] Andrew R. Willan,et al. Incremental net bene ' t in randomized clinical trials , 2001 .
[30] M Johannesson,et al. A Note on Confidence Intervals in Cost-Effectiveness Analysis , 1998, International Journal of Technology Assessment in Health Care.
[31] R. Baltussen,et al. The interpretation of results of economic evaluation: explicating the value of health. , 1997, Health economics.
[32] M J Al,et al. Costs, effects and C/E-ratios alongside a clinical trial. , 1994, Health economics.
[33] R. Gelber,et al. Quality adjusted survival analysis. , 1990, Statistics in medicine.
[34] J C Gardiner,et al. Power and sample assessments for tests of hypotheses on cost-effectiveness ratios. , 2000, Health economics.
[35] J Mullahy. What you don't know can't hurt you? Statistical issues and standards for medical technology evaluation. , 1996, Medical care.
[36] A R Willan,et al. Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data. , 1999, Health economics.
[37] A Briggs,et al. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. , 1998, Health economics.
[38] H Zhao,et al. On Estimating Medical Cost and Incremental Cost‐Effectiveness Ratios with Censored Data , 2001, Biometrics.
[39] A A Tsiatis,et al. Efficient Estimation of the Distribution of Quality‐Adjusted Survival Time , 1999, Biometrics.
[40] Andrew R Willan,et al. Incremental net benefit in randomized clinical trials with quality‐adjusted survival , 2003, Statistics in medicine.
[41] J. Heyse,et al. A regression-based method for estimating mean treatment cost in the presence of right-censoring. , 2000, Biostatistics.
[42] Robert L. Strawderman,et al. Estimating the Mean of an Increasing Stochastic Process at a Censored Stopping Time , 2000 .
[43] A A Stinnett,et al. Net Health Benefits , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.
[44] Bernie J. O'Brien,et al. In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care , 1994, Medical care.
[45] A R Willan,et al. Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem. , 1996, Health economics.